DC Bead (E7040) / Boston Scientific, Eisai  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DC Bead (E7040) / Eisai, Boston Scientific
REDEBUT, NCT01332669: Drug-eluting Bead in Hepatocellular Carcinoma

Completed
4
200
RoW
DebDox TACE, chemoembolization using drug eluting beads, DC bead chemoembolization, DebDox, TACE
Seoul National University Hospital
Hepatocellular Carcinoma
12/13
05/15
2013-001244-56: An open, multicenter, single dose, parallel study, evaluating the releaseand disposition of doxorubicin and its active metabolite (doxorubicinol)after an intra-arterial injection into the liver of an emulsion containingdoxorubicin or doxorubicin loaded into microparticulate beads in patientswith intermediate stage primary liver cancer.

Ongoing
4
28
Europe
DC Bead, iodine, doxorubicin hcl, DEB, DOX, DC Bead, Lipodol ultra fluide, Doxorubicin Teva, doxorubicin hydrochloride for injection (Adriamycine), DC Bead, Lipodol ultra fluide, Doxorubicin Teva, doxorubicin hydrochloride for injection (Adriamycine)
Department of Pharmacy, Uppsala University, Deparment of Pharmacy, Uppsala University
Intermediate hepatocellular carcinoma
 
 
NCT02525380: Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma

Unknown status
4
30
RoW
Device(DC Bead)
Seoul National University Hospital, BTG International Inc.
Hepatocellular Carcinoma
11/17
08/18

Download Options